Finance

Beta
Lists
VRDN:NASDAQ
Viridian Therapeutics Inc
$17.90
+2.93%
(+0.51) 1D
$18.07
+0.95% (+0.17)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRDN...
Open
$17.39
High
$18.38
Low
$17.38
Mkt. cap
1.98B
Avg. vol.
1.81M
Volume
5.69M
52-wk high
$34.29
52-wk low
$13.18
EPS
-$3.96
Beta
0.90
Shares outstanding
110.43M
No. of employees
252
Open
$17.39
High
$18.38
Low
$17.38
Mkt. cap
1.98B
Avg. vol.
1.81M
Volume
5.69M
52-wk high
$34.29
52-wk low
$13.18
EPS
-$3.96
Beta
0.90
Shares outstanding
110.43M
No. of employees
252
News stories
From sources across the web
About Viridian Therapeutics Inc
CEO-
Employees252
Founded2010
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websiteviridiantherapeutics.com
Analyst ratings
Based on 14 analysts giving stock ratings to VRDN in the past 3 months
Strong buy
Buy
13
Hold
1
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for VRDN in the last 3 months.
Highest
Current $17.90
$50.00 (+179.33%)
Average
$32.42 (+81.12%)
Lowest
$20.00 (+11.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Derek Archila
Wells Fargo
Hold
Maintained
$20.00
+11.7%
06/17/2026
Richard Law CFA
Goldman Sachs
Buy
Maintained
$35.00
+95.5%
06/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$26.00
+45.3%
05/15/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$39.00
+117.9%
05/13/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$35.00
+95.5%
05/09/2026
Lisa Walter
RBC Capital
Buy
Reiterated
$34.00
+89.9%
05/06/2026
Gregory Renza
Truist Financial
Buy
Maintained
$35.00
+95.5%
05/06/2026
Serge Belanger
Needham
Buy
Maintained
$32.00
+78.8%
05/05/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
05/05/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
05/05/2026
Laura Chico
Wedbush
Buy
Maintained
$32.00
+78.8%
05/05/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$22.00
+22.9%
05/06/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$50.00
+179.3%
04/06/2026
Maneka Mirchandaney
Evercore ISI
Buy
Maintained
$32.00
+78.8%
04/02/2026
Faisal Khurshid
Jefferies
Buy
Reiterated
$29.00
+62%
03/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
75.00K
70.57M
132.00K
141.00K
Cost of goods sold
86.63M
86.26M
92.71M
71.80M
Cost of revenue
86.63M
86.26M
92.71M
71.80M
Research and development expenses
-
-
-
5.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.22M
24.32M
33.67M
38.68M
Operating expense
20.22M
24.32M
33.67M
44.51M
Total operating expenses
106.84M
110.58M
126.38M
116.31M
Operating income
-106.77M
-40.01M
-126.25M
-116.17M
Other non operating income
-
453.00K
-2.12M
6.86M
EBT including unusual items
-100.74M
-34.60M
-120.36M
-104.90M
EBT excluding unusual items
-100.74M
-34.60M
-123.86M
-104.90M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-100.74M
-34.60M
-120.36M
-104.90M
Net profit margin
-134,313.33%
-49.03%
-91,178.03%
-74,397.87%
Earnings per share
-1.00
-0.34
-1.08
-0.90
Interest and investment income
6.55M
5.52M
7.79M
7.87M
Interest expense
-514.00K
-560.00K
-3.28M
-3.46M
Net interest expenses
6.03M
4.96M
4.51M
4.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
-106.65M
-39.90M
-126.13M
-116.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VRDN
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer